Anlon Healthcare develops two new anti-malarial products
The company is expected to launch both products by November 2025
Anlon Healthcare has successfully developed two new anti-malarial products, Artemether and Lumefantrine. The company is expected to launch both products by November 2025. This development is in line with its strategy to expand the product portfolio and cater to the evolving needs of its clientele.
Anlon Healthcare is a chemical manufacturing company engaged in manufacturing of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs), which are supplied to customers both in India and international markets.
